The Department of Emergency Medicine, Indiana University School of Medicine, Indianapolis, IN.
Acad Emerg Med. 2014 Apr;21(4):355-64. doi: 10.1111/acem.12342.
The aim of this review was to define the effect of prehospital therapeutic hypothermia (TH) on survival and neurologic recovery in patients who have suffered out-of-hospital cardiac arrest (OHCA).
Included in this review are randomized trials assessing the effect of prehospital TH in adult patients suffering nontraumatic OHCA. Trials assessing the effect of in-hospital TH were excluded. Only studies with a low risk of bias were eligible for meta-analysis. A medical librarian searched PubMed, Ovid, EMBASE, Ovid Global Health, the Cochrane Library, Guidelines.gov, EM Association Websites, CenterWatch, IFPMA Clinical Trial Results Portal, CINAHL, ProQuest, and the Emergency Medical Abstracts Database without language restrictions. Clinicaltrials.gov was searched for unpublished studies. Bibliographies were hand searched and experts in the field were queried about other published or unpublished trials. Using standardized forms, two authors independently extracted data from all included trials. Results from high-quality trials were pooled using a random-effects model. Two authors, using the Cochrane risk of bias tool, assessed risk of bias independently.
Of 740 citations, six trials met inclusion criteria. Four trials were at a low risk of bias and were included in the meta-analysis (N=715 patients). Pooled analysis of these trials revealed no difference in overall survival (relative risk [RR]=0.98, 95% CI=0.79 to 1.21) or good neurologic outcome (RR=0.96, 95% CI=0.76 to 1.22) between patients randomized to prehospital TH versus standard therapy. Heterogeneity was low for both survival and neurologic outcome (I2=0).
Randomized trial data demonstrate no important patient benefit from prehospital initiation of TH. Pending the results of ongoing larger trials, resources dedicated to this intervention may be better spent elsewhere.
本综述旨在确定院前治疗性低温(TH)对院外心脏骤停(OHCA)患者的生存和神经功能恢复的影响。
本综述纳入了评估成人非创伤性 OHCA 患者院前 TH 效果的随机试验。排除评估院内 TH 效果的试验。只有低偏倚风险的研究才有资格进行荟萃分析。一名医学图书馆员在无语言限制的情况下,在 PubMed、Ovid、EMBASE、Ovid 全球健康、Cochrane 图书馆、Guidelines.gov、EM 协会网站、CenterWatch、IFPMA 临床试验结果门户、CINAHL、ProQuest 和紧急医疗摘要数据库中进行了搜索。在 Clinicaltrials.gov 上搜索了未发表的研究。手动检索了参考文献,并向该领域的专家询问了其他已发表或未发表的试验。两名作者使用标准化表格,独立地从所有纳入的试验中提取数据。使用随机效应模型对高质量试验的结果进行了汇总。两名作者使用 Cochrane 偏倚风险工具,独立评估了偏倚风险。
在 740 条引文中,有 6 项试验符合纳入标准。其中 4 项试验的偏倚风险较低,被纳入荟萃分析(N=715 例患者)。对这些试验的汇总分析显示,接受院前 TH 与标准治疗的患者之间的总体生存率(相对风险 [RR]=0.98,95%置信区间 [CI]=0.79 至 1.21)或良好神经功能结局(RR=0.96,95% CI=0.76 至 1.22)无显著差异。生存率和神经功能结局的异质性均较低(I2=0)。
随机试验数据表明,院前启动 TH 对患者没有重要的获益。在正在进行的更大规模试验结果公布之前,用于该干预的资源可能会在其他地方得到更好的利用。